Login Register Cart 0
Generic placeholder image

Current Nanomedicine

Editor-in-Chief

ISSN (Print): 2468-1873
ISSN (Online): 2468-1881

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Letter to the Editor

Particulate Vaccine Dispersions Emerge as a Novel Carrier for Deep Pulmonary Immunization

Author(s): Dilpreet Singh*, Prashant Tiwari and Sanjay Nagdev

Volume 13, Issue 2, 2023

Published on: 17 July, 2023

Page: [71 - 74] Pages: 4

DOI: 10.2174/2468187313666230714124009

conference banner
« Previous Next »
[1]
Hellfritzsch M, Scherließ R. Mucosal vaccination via the respiratory tract. Pharmaceutics 2019; 11(8): 375.
[http://dx.doi.org/10.3390/pharmaceutics11080375] [PMID: 31374959]
[2]
Chow AHL, Tong HHY, Chattopadhyay P, Shekunov BY. Particle engineering for pulmonary drug delivery. Pharm Res 2007; 24(3): 411-37.
[http://dx.doi.org/10.1007/s11095-006-9174-3] [PMID: 17245651]
[3]
Kunda NK, Somavarapu S, Gordon SB, Hutcheon GA, Saleem IY. Nanocarriers targeting dendritic cells for pulmonary vaccine delivery. Pharm Res 2013; 30(2): 325-41.
[http://dx.doi.org/10.1007/s11095-012-0891-5] [PMID: 23054093]
[4]
Muralidharan P, Mallory E, Malapit M, Hayes D Jr, Mansour H. Inhalable PEGylated phospholipid nanocarriers and PEGylated therapeutics for respiratory delivery as aerosolized colloidal dispersions and dry powder inhalers. Pharmaceutics 2014; 6(2): 333-53.
[http://dx.doi.org/10.3390/pharmaceutics6020333] [PMID: 24955820]
[5]
Canelli E, Ferrari L, Borghetti P, et al. Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens. Front Vet Sci 2023; 10: 1116722.
[http://dx.doi.org/10.3389/fvets.2023.1116722] [PMID: 36998637]
[6]
Sudduth ER, Trautmann-Rodriguez M, Gill N, Bomb K, Fromen CA. Aerosol pulmonary immune engineering. Adv Drug Deliv Rev 2023; 199: 114831.
[http://dx.doi.org/10.1016/j.addr.2023.114831] [PMID: 37100206]
[7]
Vasquez-Martínez N, Guillen D, Moreno-Mendieta SA, Sanchez S, Rodríguez-Sanoja R. The role of mucoadhesion and mucopenetration in the immune response induced by polymer-based mucosal adjuvants. polymers 2023; 15(7): 1615.
[http://dx.doi.org/10.3390/polym15071615] [PMID: 37050229]
[8]
Wu H, Fu X, Zhai Y, Gao S, Yang X, Zhai G. Development of effective tumor vaccine strategies based on immune response cascade reactions. Adv Healthc Mater 2021; 10(13): 2100299.
[http://dx.doi.org/10.1002/adhm.202100299] [PMID: 34021717]
[9]
Deluco B, Wilson HL. Assessment of intestinal macromolecular absorption in young piglets to pave the way to oral vaccination: Preliminary results. Vet Res Commun 2021; 24: 1-3.
[PMID: 34559380]
[10]
Kandimalla R, John A, Abburi C, Vallamkondu J, Reddy PH. Current status of multiple drug molecules, and vaccines: An update in SARS-CoV-2 therapeutics. Mol Neurobiol 2020; 57(10): 4106-16.
[http://dx.doi.org/10.1007/s12035-020-02022-0] [PMID: 32671688]
[11]
Masjedi M, Montahaei T, Sharafi Z, Jalali A. Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy. J Drug Deliv Sci Technol 2022; 69: 103184.
[http://dx.doi.org/10.1016/j.jddst.2022.103184]
[12]
Muralidharan P, Malapit M, Mallory E, Hayes D Jr, Mansour HM. Inhalable nanoparticulate powders for respiratory delivery. Nanomedicine 2015; 11(5): 1189-99.
[http://dx.doi.org/10.1016/j.nano.2015.01.007] [PMID: 25659645]
[13]
Wang H, Connaughton P, Lachacz K, et al. Inhalable microparticle platform based on a novel shell-forming lipid excipient and its feasibility for respirable delivery of biologics. Eur J Pharm Biopharm 2022; 177: 308-22.
[http://dx.doi.org/10.1016/j.ejpb.2022.07.013] [PMID: 35905804]
[14]
Fourie PB, Germishuizen WA, Wong Y-L, Edwards DA. Spray drying TB vaccines for pulmonary administration. Expert Opin Biol Ther 2008; 8(7): 857-63.
[http://dx.doi.org/10.1517/14712598.8.7.857] [PMID: 18564902]
[15]
Foged C. Subunit vaccines of the future: The need for safe, customized and optimized particulate delivery systems. Ther Deliv 2011; 2(8): 1057-77.
[http://dx.doi.org/10.4155/tde.11.68] [PMID: 22826868]
[16]
Minnie SA, Hill GR. Immunotherapy of multiple myeloma. J Clin Invest 2020; 130(4): 1565-75.
[http://dx.doi.org/10.1172/JCI129205] [PMID: 32149732]
[17]
Zhang R, Tang L, Tian Y, et al. DP7-C-modified liposomes enhance immune responses and the antitumor effect of a neoantigen-based mRNA vaccine. J Control Release 2020; 328(328): 210-21.
[http://dx.doi.org/10.1016/j.jconrel.2020.08.023] [PMID: 32860927]

Rights & Permissions Print Cite
Article Metrics
9
1
Wayfinder Image
World Rabies Day
© 2024 Bentham Science Publishers | Privacy Policy